Search Results
Search for other papers by Aglaia Kyrilli in
Google Scholar
PubMed
Search for other papers by Nunzia Tacelli in
Google Scholar
PubMed
Search for other papers by Lucia Russo in
Google Scholar
PubMed
Search for other papers by Laetitia Lebrun in
Google Scholar
PubMed
Search for other papers by Isabelle Salmon in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Rodrigo Moreno-Reyes in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
eluded recruitment procedure, and so were excluded. Twenty-seven out of the 36 euthyroid patients with AFTN underwent 123 I scintigraphy which was positive and concordant with 99m TcO 4 − for the presence of an AFTN for all cases but 2, so the latter
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Fernando Schmitt in
Google Scholar
PubMed
Search for other papers by Paula Soares in
Google Scholar
PubMed
Search for other papers by Tamas Solymosi in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
undergoing FNA ,’ and Fig. 1 ( See related sections for grading and agreement ) Thyroid hormone treatment is not indicated in euthyroid individuals with nodular thyroid disease ( Strength of recommendation: 1; quality of evidence: ØØØO. Agreement: 9
Search for other papers by Eduardo Crespo Vallejo in
Google Scholar
PubMed
Search for other papers by Antonio Hermosin in
Google Scholar
PubMed
Search for other papers by Manuel Gargallo in
Google Scholar
PubMed
Search for other papers by Álvaro Villalba in
Google Scholar
PubMed
Search for other papers by Eduardo Daguer in
Google Scholar
PubMed
Search for other papers by José Flores in
Google Scholar
PubMed
Search for other papers by Javier Periañez in
Google Scholar
PubMed
Search for other papers by Joaquim Amorín in
Google Scholar
PubMed
Search for other papers by Ernesto Santos in
Google Scholar
PubMed
hyperthyroidism and in 5 of them, it was the only indication. Around 16 of the patients were euthyroid, 2 had hyperthyroidism, 7 had subclinical hyperthyroidism, 3 were hypothyroid, and 2 had subclinical hypothyroidism. Characteristics of the nodule to be
Department of Radiology, Jichi Medical University, School of Medicine, Shimotsuke, Tochigi, Japan
Search for other papers by Tomohiro Kikuchi in
Google Scholar
PubMed
Search for other papers by Shouhei Hanaoka in
Google Scholar
PubMed
Search for other papers by Takahiro Nakao in
Google Scholar
PubMed
Center for Frontier Medical Engineering, Chiba University, Yayoicho, Inage–ku, Chiba, Japan
Search for other papers by Yukihiro Nomura in
Google Scholar
PubMed
Search for other papers by Takeharu Yoshikawa in
Google Scholar
PubMed
Search for other papers by Ashraful Alam in
Google Scholar
PubMed
Search for other papers by Harushi Mori in
Google Scholar
PubMed
Search for other papers by Naoto Hayashi in
Google Scholar
PubMed
of the pathophysiology might have been possible. In particular, it could be a factor that characterizes false-positive (euthyroid participants with high SUV) and false-negative (hypothyroid participants with low SUV) in the present study. In
Search for other papers by M Grussendorf in
Google Scholar
PubMed
Search for other papers by I Ruschenburg in
Google Scholar
PubMed
Search for other papers by G Brabant in
Google Scholar
PubMed
. with malignancies ROM (%) Euthyroid goiter 11,109 2851 13,960 79.4 171 1.3 Graves’ disease 356 56 412 2.3 2 0.5 Autoimmune thyroiditis 906 68 974 5.5 5 0.5 Toxic adenoma 1540 373